Exchange Agreements in the Pharmaceuticals Industry
397 Contracts & Agreements
- Acacia Diversified Holdings, Inc. (1 contract)
- Accelerated Pharma, Inc. (4)
- Acer Therapeutics Inc. (1)
- ACHILLION PHARMACEUTICALS INC (4)
- ACURA PHARMACEUTICALS, INC (1)
- Adamis Pharmaceuticals Corp (1)
- ADIAL PHARMACEUTICALS, INC. (1)
- Aegerion Pharmaceuticals, Inc. (2)
- AEOLUS PHARMACEUTICALS, INC. (1)
- AERIE PHARMACEUTICALS INC (1)
- Akorn (1)
- ALIMERA SCIENCES INC (1)
- Allergan, plc (1)
- Amag Pharmaceuticals (11)
- Amphastar Pharma (1)
- Ampio Pharmaceuticals, Inc. (1)
- ANI Pharma Inc (17)
- Anthera Pharmaceuticals Inc (1)
- Applied BioSciences Corp. (1)
- ARIAD PHARMACEUTICALS INC (1)
- Artemis Therapeutics, Inc. (5)
- Assertio Holdings, Inc. (1)
- Assertio Therapeutics, Inc (1)
- ATAI Life Sciences B.V. (1)
- AUXILIUM PHARMACEUTICALS INC (1)
- AVADEL PHARMACEUTICALS PLC (4)
- AVANIR PHARMACEUTICALS, INC. (2)
- AXIM BIOTECHNOLOGIES, INC. (1)
- Axsome Therapeutics, Inc. (3)
- AYTU BIOSCIENCE, INC (5)
- Bausch Health Companies Inc. (2)
- Bespoke Extracts, Inc. (4)
- Biofrontera Inc. (1)
- BioPharmX Corp (2)
- Biostar Pharmaceuticals, Inc. (2)
- Boston Therapeutics, Inc. (3)
- Bristol-Myers Squibb (5)
- CALLISTO PHARMACEUTICALS INC (1)
- Canbiola, Inc. (2)
- CANNAPHARMARX, INC. (2)
- Canopy Growth Corp (2)
- Catalent Inc (2)
- Celexus, Inc (2)
- Cerecor Inc. (1)
- CHINA PEDIATRIC PHARMACEUTICALS, INC. (2)
- China Pharmaceuticals Inc (1)
- China Yongxin Pharmaceuticals Inc. (1)
- Clearside Biomedical, Inc. (1)
- CLS Holdings USA, Inc. (2)
- COLLAGENEX PHARMACEUTICALS INC (4)
- CorMedix Inc. (5)
- CUMBERLAND PHARMACEUTICALS INC (9)
- Cure Pharmaceutical Holding Corp. (1)
- Egalet Corp (2)
- ELITE PHARMACEUTICALS INC (2)
- Eloxx Pharmaceuticals, Inc. (6)
- Endexx Corp (3)
- Endo International plc (1)
- Endo Pharmaceuticals Solutions Inc. (1)
- EPHS HOLDINGS, INC. (4)
- EPIX Pharmaceuticals, Inc. (1)
- Evofem Biosciences, Inc. (9)
- Evoke Pharma Inc (1)
- Exactus, Inc. (7)
- FRONTIER OILFIELD SERVICES INC (2)
- GENAISSANCE PHARMACEUTICALS INC (2)
- GridIron BioNutrients, Inc. (2)
- GUILFORD PHARMACEUTICALS INC (1)
- HARROW HEALTH, INC. (1)
- Horizon Pharma plc (1)
- IDENIX PHARMACEUTICALS INC (1)
- IMAGING3 INC (1)
- INNOVATE BIOPHARMACEUTICALS, INC. (2)
- Item 9 Labs Corp. (1)
- Jaguar Health, Inc. (9)
- Jiangbo Pharmaceuticals, Inc. (1)
- Kannalife Inc (1)
- Kaya Holdings, Inc. (2)
- Kedem Pharmaceuticals Inc. (2)
- KEMPHARM, INC (7)
- KOLLTAN PHARMACEUTICALS INC (1)
- Lannett Company, Inc. (2)
- Longboard Pharmaceuticals, Inc. (1)
- Lotus Pharmaceuticals, Inc. (1)
- Mallinckrodt (2)
- Marijuana Co of America, Inc. (2)
- MARINUS PHARMACEUTICALS INC (2)
- MedGen, Inc. (2)
- Medicine Man Technologies, Inc. (2)
- MERA PHARMACEUTICALS INC (1)
- MICROCHANNEL TECHNOLOGIES CORP (2)
- Milestone Pharmaceuticals Inc. (1)
- MILLENNIUM PHARMACEUTICALS INC (2)
- MJ Holdings, Inc. (1)
- Molecular Insight Pharmaceuticals, Inc. (1)
- MYnd Analytics, Inc. (5)
- NEKTAR THERAPEUTICS (9)
- NewBridge Global Ventures, Inc. (5)
- NEXIEN BIOPHARMA, INC. (1)
- Notis Global, Inc. (1)
- Novan, Inc. (2)
- NOVEN PHARMACEUTICALS INC (1)
- Onconova Therapeutics, Inc. (1)
- OptiNose, Inc. (1)
- ORAMED PHARMACEUTICALS INC. (6)
- OSCIENT PHARMACEUTICALS CORP (3)
- Pacira Pharmaceuticals, Inc. (10)
- PaxMedica, Inc. (1)
- PetLife Pharmaceuticals, Inc. (1)
- Phibro Animal Health Corporation (1)
- Pivot Pharmaceuticals Inc. (3)
- PRAECIS PHARMACEUTICALS INC (4)
- PROTEO INC (1)
- PROVECTUS BIOPHARMACEUTICALS, INC. (1)
- QUANTA INC (1)
- Ra Pharmaceuticals, Inc. (2)
- RADIENT PHARMACEUTICALS Corp (6)
- Rain Therapeutics Inc. (2)
- Rani Therapeutics Holdings, Inc. (2)
- Recro Pharma, Inc. (3)
- RELMADA THERAPEUTICS, INC. (2)
- RespireRx Pharmaceuticals Inc. (16)
- Royalty Pharma plc (3)
- SALIX PHARMACEUTICALS LTD (1)
- SAVIENT PHARMACEUTICALS INC (1)
- Scopus BioPharma Inc. (3)
- Sienna Biopharmaceuticals, Inc. (3)
- SIGA TECHNOLOGIES INC (3)
- Sucampo Pharmaceuticals, Inc. (1)
- SUNWIN STEVIA INTERNATIONAL, INC. (1)
- Supernus Pharmaceuticals, Inc. (1)
- SYNERGY PHARMACEUTICALS, INC. (2)
- Target Group Inc. (2)
- Terra Tech Corp. (2)
- TETRALOGIC PHARMACEUTICALS CORP (3)
- TETRAPHASE PHARMACEUTICALS INC (2)
- Textmunication Holdings, Inc. (4)
- The Medicines Company (20)
- Urigen Pharmaceuticals, Inc. (1)
- VION PHARMACEUTICALS INC (1)
- Vitality Biopharma, Inc. (4)
- Vyrix Pharmaceuticals, Inc. (2)
- WEED, INC. (1)
- XERIS PHARMACEUTICALS INC (1)
- Zoetis (1)
- ZOGENIX, INC. (13)
- Streeterville Exchange Agreement (Jaguar Health, Inc., Filed With SEC on March 1, 2024)
- Share Exchange Agreement, dated February 20, 2024 (Textmunication Holdings, Inc., Filed With SEC on February 26, 2024)
- Exchange Agreement dated as of February 21, 2024 (MYnd Analytics, Inc., Filed With SEC on February 26, 2024)
- Form of Amendment and Preferred Exchange Agreement (Evofem Biosciences, Inc., Filed With SEC on December 27, 2023)
- Form of Waiver and Rights Exchange Agreement (Evofem Biosciences, Inc., Filed With SEC on December 27, 2023)
- Exchange Agreement dated as of December 15, 2023 (MYnd Analytics, Inc., Filed With SEC on December 20, 2023)
- Exchange Agreement, dated September 29, 2023, by and between Jaguar Health, Inc. and Uptown Capital, LLC (Jaguar Health, Inc., Filed With SEC on October 5, 2023)
- Stock Purchase Agreement dated August 31, 2023, by and between the Company and Mr. Roger L. Collins, Jr. Schedules and exhibits to this document are omitted pursuant to Item... (Vitality Biopharma, Inc., Filed With SEC on September 5, 2023)
- Form of Exchange Agreement (Evofem Biosciences, Inc., Filed With SEC on August 10, 2023)
- Form of Exchange Agreement dated June 29, 2023, by and between Canopy Growth Corporation and the Holders (Canopy Growth Corp, Filed With SEC on July 3, 2023)
- Form of Exchange Agreement (Jaguar Health, Inc., Filed With SEC on July 3, 2023)
- Exchange Agreement, dated as of (Cerecor Inc., Filed With SEC on June 2, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between John M. Hamm and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 12, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Chris Bitterman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 12, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Todd Anthony and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 12, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between Jim Herman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 12, 2023)
- Employment Agreement dated March 9, 2023, effective as of January 1, 2023, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 12, 2023)
- Form of Exchange Agreement (Scopus BioPharma Inc., Filed With SEC on April 14, 2023)
- Exchange Agreement, dated as of April 13, 2023, by and between Canopy Growth Corporation and Greenstar Canada Investment Limited Partnership (Canopy Growth Corp, Filed With SEC on April 14, 2023)
- Form of Exchange Agreement between the Issuer, the Company and certain holders of the 2023 Notes (AVADEL PHARMACEUTICALS PLC, Filed With SEC on March 29, 2023)
- Exchange Agreement, dated as of March 22, 2023, by and among the Company and certain investors party thereto (Milestone Pharmaceuticals Inc., Filed With SEC on March 27, 2023)
- Form of Exchange Agreement (Assertio Holdings, Inc., Filed With SEC on February 23, 2023)
- Form of Exchange Agreement (Biofrontera Inc., Filed With SEC on October 31, 2022)
- Form of Exchange Agreement (Scopus BioPharma Inc., Filed With SEC on October 20, 2022)
- Exchange Agreement between Relmada Therapeutics, Inc., and Venrock Healthcare Capital Partners EG, L.P., Venrock Healthcare Capital Partners II, L.P., VHCP Co-Investment Holdings... (RELMADA THERAPEUTICS, INC., Filed With SEC on September 22, 2022)
- Form of Adjuvant Exchange Agreement (Evofem Biosciences, Inc., Filed With SEC on September 16, 2022)
- Form of Investor Exchange Agreement (Evofem Biosciences, Inc., Filed With SEC on September 16, 2022)
- Form of Contribution and Exchange Agreement among the registrant, CBD Unlimited, Inc., Todd Allen Davis, and Rayne Forecast Inc., effective August 31 (Endexx Corp, Filed With SEC on September 7, 2022)
- Form of Series Seed Exchange Agreement (PaxMedica, Inc., Filed With SEC on August 8, 2022)
- Share Exchange Agreement with Hempirical Genetics, LLC dated May 2, 2022 (WEED, INC., Filed With SEC on August 4, 2022)
- First Amendment to the Share Exchange Agreement by and between Artemis Therapeutics, Inc., Manuka Ltd., an Israeli company and the shareholders of Manuka Ltd., dated June 30, 2022 (Artemis Therapeutics, Inc., Filed With SEC on July 5, 2022)
- Arena Exchange Agreement (Canbiola, Inc., Filed With SEC on June 30, 2022)
- Share Exchange Agreement by and between Artemis Therapeutics, Inc., Manuka Ltd., an Israeli company and the shareholders of Manuka Ltd., dated March 6, 2022 (Artemis Therapeutics, Inc., Filed With SEC on May 23, 2022)
- Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between James L. Herman and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 13, 2022)
- Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between John M. Hamm and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 13, 2022)
- Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between Leo B. Pavliv and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 13, 2022)
- Employment Agreement dated March 7, 2022, effective as of January 1, 2022, by and between A.J. Kazimi and Cumberland Pharmaceuticals Inc. (incorporated by reference to Exhibit... (CUMBERLAND PHARMACEUTICALS INC, Filed With SEC on May 13, 2022)
- Form of Amendment and Exchange Agreement For Equity Line Shares (Evofem Biosciences, Inc., Filed With SEC on May 5, 2022)
- Form of Amendment and Exchange Agreement For Preferred Stock (Evofem Biosciences, Inc., Filed With SEC on May 5, 2022)
- Form of Amendment and Exchange Agreement For Existing Notes (Evofem Biosciences, Inc., Filed With SEC on May 5, 2022)
